Redpoint Bio Corporation Stock

Equities

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-.--%

2013	Redpoint Bio Corporation cancelled the transaction announced on July 16, 2012.	CI
2012	Redpoint Bio Corporation cancelled the acquisition of Celator Pharmaceuticals, Inc. from Domain Associates, L.L.C., BDC Diversified Venture Fund of BDC Venture Capital, GrowthWorks Access Fund Limited Partnership of Matrix Asset Management Inc., Quaker BioVentures, Thomas, McNerney & Partners, TL Ventures, Ventures West Management Inc. and others.	CI

Duration

Period

Style

Redpoint Bio Corporation cancelled the transaction announced on July 16, 2012.	13-07-16	CI
Redpoint Bio Corporation cancelled the acquisition of Celator Pharmaceuticals, Inc. from Domain Associates, L.L.C., BDC Diversified Venture Fund of BDC Venture Capital, GrowthWorks Access Fund Limited Partnership of Matrix Asset Management Inc., Quaker BioVentures, Thomas, McNerney & Partners, TL Ventures, Ventures West Management Inc. and others.	12-08-09	CI
Redpoint Bio Corporation announced that it expects to receive $40 million in funding.	12-07-16	CI
Redpoint Bio Corporation entered into an exchange transaction agreement to acquire Celator Pharmaceuticals, Inc. from Domain Associates, L.L.C., BDC Diversified Venture Fund of BDC Venture Capital, GrowthWorks Access Fund Limited Partnership of Matrix Asset Management Inc., Quaker BioVentures, Thomas, McNerney & Partners, TL Ventures, Ventures West Management Inc. and others.	12-06-17	CI
Redpoint Bio Corporation Auditor Raises 'Going Concern' Doubt	12-04-16	CI
Redpoint Bio Corporation Announces Resignation of F. Raymond Salemme as Member of the Board of Directors, Effective as of January 31, 2012	12-01-26	CI

REDPOINT BIO CORP : Redpoint Bio Reports Three Months and Nine Months Ended September 30, 2010 Results	10-11-09	PR
REDPOINT BIO CORP : Redpoint Announces Generally Recognized As Safe (GRAS) Determination for RP44 Sweetness Enhancer	10-11-03	PR
REDPOINT BIO CORP : Redpoint Bio to Present at Rodman & Renshaw Annual Global Investment Conference	10-09-07	PR
REDPOINT BIO CORP : Redpoint Bio Reports Three Months and Six Months Ended June 30, 2010 Results	10-08-13	PR
REDPOINT BIO CORP : Redpoint Bio Receives U.S. Patent Covering Screening Technology	10-07-28	PR

Redpoint Bio Corp is a United States-based company. The Company is engaged in research and development in physical, engineering and life sciences.

Sector

	1st Jan change	Capi.
REDPOINT BIO CORPORATION	-.--%	7.99K
IQVIA HOLDINGS INC.	+3.13%	43.43B
LONZA GROUP AG	+48.43%	41.69B
MODERNA, INC.	+8.49%	41.31B
CELLTRION, INC.	-10.82%	27.14B
ICON PUBLIC LIMITED COMPANY	+8.26%	25.28B
ALNYLAM PHARMACEUTICALS, INC.	-23.69%	18.47B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.58%	12.33B
MEDPACE HOLDINGS, INC.	+32.83%	12.59B
UNITED THERAPEUTICS CORPORATION	+6.63%	11.03B